These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31540207)

  • 21. BCL2 Regulates Differentiation of Intestinal Fibroblasts.
    Weder B; Mamie C; Rogler G; Clarke S; McRae B; Ruiz PA; Hausmann M
    Inflamm Bowel Dis; 2018 Aug; 24(9):1953-1966. PubMed ID: 29796658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fibrogenesis and inflammatory bowel disease].
    Sans M; Masamunt MC
    Gastroenterol Hepatol; 2007 Jan; 30(1):36-41. PubMed ID: 17266880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel.
    Hiraishi K; Kurahara LH; Sumiyoshi M; Hu YP; Koga K; Onitsuka M; Kojima D; Yue L; Takedatsu H; Jian YW; Inoue R
    World J Gastroenterol; 2018 Sep; 24(35):4036-4053. PubMed ID: 30254408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
    Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J
    Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can we influence fibrosis in Crohn's disease?
    Assche GV
    Acta Gastroenterol Belg; 2001; 64(2):193-6. PubMed ID: 11475134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crohn's Disease: Potential Drugs for Modulation of Autophagy.
    Azzman N
    Medicina (Kaunas); 2019 May; 55(6):. PubMed ID: 31146413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin alleviates cardiac fibrosis in mice by inhibiting autophagy.
    Liu PP; Liu HH; Sun SH; Shi XX; Yang WC; Su GH; Zhao J
    Acta Pharmacol Sin; 2017 Apr; 38(4):488-497. PubMed ID: 28216620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of fibrosis and stricture formation in Crohn's disease.
    Alfredsson J; Wick MJ
    Scand J Immunol; 2020 Dec; 92(6):e12990. PubMed ID: 33119150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of pentoxifylline and its metabolite-1 on inflammation and fibrosis in the TNBS model of colitis.
    Peterson TC; Peterson MR; Raoul JM
    Eur J Pharmacol; 2011 Jul; 662(1-3):47-54. PubMed ID: 21554874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete induction of autophagy is essential for cardioprotection in sepsis.
    Hsieh CH; Pai PY; Hsueh HW; Yuan SS; Hsieh YC
    Ann Surg; 2011 Jun; 253(6):1190-200. PubMed ID: 21412148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease.
    Stallmach A; Schuppan D; Riese HH; Matthes H; Riecken EO
    Gastroenterology; 1992 Jun; 102(6):1920-9. PubMed ID: 1587410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant contribution of TRPC6 channel-mediated Ca
    Kurahara LH; Hiraishi K; Sumiyoshi M; Doi M; Hu Y; Aoyagi K; Jian Y; Inoue R
    J Smooth Muscle Res; 2016; 52(0):78-92. PubMed ID: 27818466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of noncontrast MRI magnetization transfer and T2 -Weighted signal intensity ratios for detection of bowel wall fibrosis in a Crohn's disease animal model.
    Dillman JR; Swanson SD; Johnson LA; Moons DS; Adler J; Stidham RW; Higgins PD
    J Magn Reson Imaging; 2015 Sep; 42(3):801-10. PubMed ID: 25504823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets.
    Lewis A; Nijhuis A; Mehta S; Kumagai T; Feakins R; Lindsay JO; Silver A
    Inflamm Bowel Dis; 2015 May; 21(5):1141-50. PubMed ID: 25636122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pirfenidone inhibits the proliferation of fibroblasts from patients with active Crohn's disease.
    Kadir SI; Wenzel Kragstrup T; Dige A; Kok Jensen S; Dahlerup JF; Kelsen J
    Scand J Gastroenterol; 2016 Nov; 51(11):1321-5. PubMed ID: 27181436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel collagen area fraction index to quantitatively assess bowel fibrosis in patients with Crohn's disease.
    Li XH; Fang ZN; Guan TM; Lin JJ; Sun CH; Huang SY; Mao R; Lu BL; Cao QH; Feng ST; Li ZP
    BMC Gastroenterol; 2019 Nov; 19(1):180. PubMed ID: 31711420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy inhibition attenuates the induction of anti-inflammatory effect of catalpol in liver fibrosis.
    Liu Z; Zhu P; Zhang L; Xiong B; Tao J; Guan W; Li C; Chen C; Gu J; Duanmu J; Zhang W
    Biomed Pharmacother; 2018 Jul; 103():1262-1271. PubMed ID: 29864907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's disease.
    Burke JP; Ferrante M; Dejaegher K; Watson RW; Docherty NG; De Hertogh G; Vermeire S; Rutgeerts P; D'Hoore A; Penninckx F; Geboes K; Van Assche G; O'Connell PR
    Inflamm Bowel Dis; 2008 Sep; 14(9):1197-204. PubMed ID: 18452219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can Contrast-Enhanced Sonography Detect Bowel Wall Fibrosis in Mixed Inflammatory and Fibrotic Crohn Disease Lesions in an Animal Model?
    Dillman JR; Rubin JM; Johnson LA; Moons DS; Higgins PD
    J Ultrasound Med; 2017 Mar; 36(3):523-530. PubMed ID: 28072481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases.
    Szabò H; Fiorino G; Spinelli A; Rovida S; Repici A; Malesci AC; Danese S
    Aliment Pharmacol Ther; 2010 Jan; 31(2):189-201. PubMed ID: 19832726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.